Stereoselective central nervous system effects of the R- and S-isomers of the GABA uptake blocker N-(4,4-di-(3-methylthien-2-yl)but-3-enyl) nipecoticacid in the rat

1 The 'effect compartment' model was applied to characterize the pharmacody namics of the R and S-isomers of tiagabine in conscious rats in vivo using increase in the beta activity of the EEG as a pharmacodynamic endpoint. 2 No pharmacokinetic differences in plasma were observed between R- and S-t iagabine. The values for clearance and volume of distribution at steady-sta te were 103 +/- 10 versus 90+/-6 mi min(-1) kg(-1) and 1.8 +/- 0.2 versus 1 .6 +/- 0.2 1 kg(-1) for the R- and S-isomer, respectively. In contrast, pla sma protein binding showed a statistically significant difference with valu es of the free fraction of 5.7 +/- 0.5 and 11.4+/-0.6%. In addition the rat e constant for transport to the effect compartment was also different with values of 0.027 versus 0.067 min(-1). 3 For both isomers the relationship between concentration and EEG effect wa s non-linear and successfully characterized on basis of the Hill equation. A statistically significant difference in the value of EC50 Of 328 +/- 11 v ersus 604 +/- 18 ng ml(-1) was observed for R- and S-tiagabine respectively . The values of the other pharmacodynamic parameters were identical. 4 It is concluded that the differences in in vivo pharmacodynamics of R- an d S-tiagabine can be explained by stereoselective differences in both the a ffinity to the GABA-uptake transporter and the degree of non-specific prote in binding in plasma and at the effect site.